Top Democratic Consultants Work for Anti–Medicare for All Campaign
The industry-led Partnership for America’s Health Care Future, which has assailed Democratic presidential candidates’ reform plans, is drawing on Democratic firms for assistance.
Page 7
The industry-led Partnership for America’s Health Care Future, which has assailed Democratic presidential candidates’ reform plans, is drawing on Democratic firms for assistance.
The leading pharmaceutical lobby gave to numerous Republican groups—and one key Democratic one.
Freshman Rep. Anthony Brindisi (D-N.Y.) is advocating a 10-year exclusivity period for biologic drugs as the Blue Dog PAC takes maxed-out donations from the pharmaceutical industry.
With a clearer picture of how Medicare for All can be financed through reducing military spending, voters can debate the merits of a single-payer system without needing to consider any new taxes.
The 19-member panel that advises the Congressional Budget Office on health policy is flush with health insurance, pharmaceutical, and hospital interests.
Buttigieg’s recent transformation into explicit Medicare for All critic was accompanied by continued donations from pharmaceutical and health insurance interests.
The bill is backed by both Trump and Pelosi, so McConnell is standing in the way of a major bipartisan breakthrough that could lower drug prices for millions of Americans.
Heidi Heitkamp’s One Country Project urges Democrats to take a moderate approach to climate change.
The Coalition Against Socialized Medicine, a project of the American Conservative Union, is advertising on Politico Playbook this week.
Trump and Indian Prime Minister Narendra Modi are discussing an agreement that would lock the world’s second-most-populous country into exclusive prescription drug arrangements.